Yoo-Jin Kim

10PUBLICATIONS
26CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Respiratory diseasesCardiology (incl. cardiovascular diseases)Medical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 10, 2026
Prognostic value of early lymphocyte dynamics during blinatumomab therapy in relapsed or refractory B-cell precursor acute lymphoblastic leukemia: A real-world retrospective study.

|Aug 26, 2026
Real-World Outcomes of Tisagenlecleucel Versus Standard-of-Care Salvage Chemotherapy in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Propensity Score-Matched Analysis From Korea.

|Apr 16, 2026
Individualized decitabine dosing for post-HSCT maintenance in MDS and secondary AML from MDS: long-term outcomes from the PODAC trial and matched controls.

|Nov 05, 2024
Beneficial effects of cellular immunotherapy in the prevention and treatment of posttransplant hematologic relapse of myelodysplastic neoplasms.

Gi-June Min, Sung Soo Park, Silvia Park

|Mar 10, 2023
Superior survival outcome of blinatumomab compared with conventional chemotherapy for adult patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia: a propensity score-matched cohort analysis.

Jae-Ho Yoon, Daehun Kwag, Jong-Hyuk Lee

|Mar 28, 2022
A retrospective comparison of salvage intensive chemotherapy versus venetoclax-combined regimen in patients with relapsed/refractory acute myeloid leukemia (AML).

Silvia Park, Daehun Kwag, Tong Yoon Kim

Pageof 2

Frequent Collaborators

8 joint publications

Sung Soo Park

5 joint publications

Jong Wook Lee

5 joint publications

Sung-Eun Lee

4 joint publications

Silvia Park